Form D · Biotechnology
ReAlta Life Sciences, Inc.
Norfolk, VA · CIK 0001752530
Offering snapshot reported May 21, 2025 · SEC filing
- Reported sold
- $29.9M Offering amount: $30M
- Investors reported
- 149 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2025 | Initial | $29,929,943 | No comparison | 149 | SEC filing |
| May 21, 2025 | Initial | $25,000,141 | No comparison | 109 | SEC filing |
| May 21, 2025 | Initial | $11,999,998 | No comparison | 85 | SEC filing |
| Sep 13, 2023 | Initial | $22,500,017 | No comparison | 92 | SEC filing |
| Feb 19, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 28, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 12, 2018 | Initial | $4,847,346 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546735
Shares of Series A-5 Preferred Stock and underlying shares of common stock issuable upon conversion thereof
Source: Form D, filed May 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kathryn Abshire | Executive |
| Mert Aktar | Director |
| Kenji Cunnion | Executive |
| Frank Gadams | Director |
| Deborah Geraghty | Director |
| Laurie Glimcher | Director |
| John Harding | Director, Executive |
| Edward Heidt, Jr. | Director |
| Neel Krishna | Executive |
| David Marek | Director, Executive |
| Paolo Martini | Executive |
| Thomas Kerry Mc Carter | Executive |
| Andrew Miller | Director |
| Azmi Nabulsi | Director |
| Jerry Nadler | Director |
| Christine Neikirk | Director |
| Emma Reeve | Director |
| John Rickman | Executive |
| Christi Shaw | Director |
| Barry Strasnick | Director |
| Ulrich Thienel | Director, Executive |
| Lewis Williams | Director |
| Jonathan Zalevsky | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5665 Lowery Road, Suite 100
Norfolk, VA, 23502
Norfolk, VA, 23502